Quadrant Capital Group LLC Harmony Biosciences Holdings, Inc. Transaction History
Quadrant Capital Group LLC
- $1.43 Billion
- Q4 2024
A detailed history of Quadrant Capital Group LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 308 shares of HRMY stock, worth $10,087. This represents 0.0% of its overall portfolio holdings.
Number of Shares
308
Previous 382
19.37%
Holding current value
$10,087
Previous $15,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HRMY
# of Institutions
254Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$217 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$191 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$155 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$74.7 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$51.8 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.94B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...